• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Digital Health | News, Analysis, Insights - HIT Consultant

Qure.ai Appoints Jim Mercadante as Chief Commercial Officer

by Healthcare Executive Hires 01/09/2025 Leave a Comment

What You Should Know: - Qure.ai, a global provider of AI-powered healthcare solutions, announced the appointment of Jim Mercadante as its new Chief Commercial Officer. - Based in New York, Mercadante will lead the company's global sales and business development strategy, driving further expansion and market penetration. Mercadante Bio/Background Jim Mercadante brings extensive experience in commercial leadership, sales, business growth, and strategic marketing within the healthcare industry. He has held leadership positions at prominent companies such as Abbott, Johnson & Johnson, GE, Terumo, and most recently, Rapid AI. With a strong presence in over 90 countries, Qure.ai has experienced significant growth in Asia, Africa, the Middle East, and Europe. The company's AI-powered solutions are now gaining traction in North and South America, creating the need for expanded commercial leadership. With Mercadante's leadership and the support of its recent funding, Qure.ai is well-positioned to continue its rapid growth and solidify its position as a global leader in AI-driven healthcare solutions. "Qure.ai stands out for its exceptional people, cutting-edge technology, and clear vision for the future of healthcare. I’m excited to contribute to the company’s growth as we continue to expand globally and develop AI solutions that address critical healthcare challenges," said Jim Mercadante, Chief Commercial Officer of Qure.ai.

What You Should Know:  - Qure.ai, a global provider of AI-powered healthcare solutions, announced the appointment of Jim Mercadante as its new Chief Commercial Officer.  - Based in New York, Mercadante will lead the company's global sales and business development strategy, driving further expansion and market penetration. Mercadante Bio/Background Jim Mercadante brings extensive experience in commercial leadership, sales, business growth, and strategic marketing within the
Read More

AI in Healthcare: Enhancing the Patient Experience with Compassionate, Secure Virtual Agents

by Frank Fawzi, IntelePeer CEO 01/09/2025 Leave a Comment

AI in Healthcare: Enhancing the Patient Experience with Compassionate, Secure Virtual Agents

In today’s digital-first world, AI-powered automation is redefining how we approach both customer and healthcare patient experiences. While AI has already made its mark across industries, its application in healthcare introduces a unique opportunity to enhance patient experience (PX) at a time when the industry is grappling with unprecedented challenges, including staffing shortages and increased demand. Virtual AI agents, equipped with advanced conversational abilities, can now assist patients
Read More

FIRE1 Secures $120M for Heart Failure Management Platform

by Fred Pennic 01/08/2025 Leave a Comment

FIRE1 Secures $120M for Heart Failure Management Platform

What You Should Know:  - FIRE1, a connected medical device company, announced it has secured $120M in funding to advance its mission to transform the lives of millions of people living with heart failure. The round was led by Polaris Partners and Elevage Medical Technologies, joined by new investors Sands Capital and Longitude Capital, and existing investors Andera Partners, Gilde Healthcare, Gimv, the Ireland Strategic Investment Fund, Lightstone Ventures, Medtronic, NEA (New Enterprise
Read More

Transcarent to Acquire Accolade in $621M Deal, Creating a Unified Platform for Personalized Healthcare

by Fred Pennic 01/08/2025 Leave a Comment

Transcarent to Acquire Accolade in $621 Million Deal, Creating a Unified Platform for Personalized Healthcare

What You Should Know:  - Transcarent, a health and care platform, announced today that it will acquire Accolade (NASDAQ: ACCD), a leader in health advocacy and primary care, for $7.03 per share in cash, representing a total equity value of approximately $621M.  The merger consideration represents a significant premium over Accolade's recent stock price, reflecting the strategic value of this transaction. Transcarent will finance the acquisition through equity financing led by
Read More

ScreenPoint Medical Acquires Biomediq to Enhance Breast Cancer Risk Assessment with AI

by Fred Pennic 01/08/2025 Leave a Comment

ScreenPoint Medical Acquires Biomediq to Enhance Breast Cancer Risk Assessment with AI

What You Should Know:  - ScreenPoint Medical, a provider of AI-powered breast cancer screening solutions, acquires Biomediq A/S, a research-based company specializing in quantitative imaging biomarkers. Financial details of the acquisition were not disclosed.  - ScreenPoint's industry-leading Transpara AI platform will now incorporate Biomediq's advanced risk analysis technology, which enables automated analysis of 2D and 3D mammograms to assess future breast cancer risk. This
Read More

Mashura Secures $300M Strategic Partnership with PE Firm Warburg Pincus

by Fred Pennic 01/07/2025 Leave a Comment

Mashura Secures $300M Strategic Partnership with PE Firm Warburg Pincus

What You Should Know:  - Mashura, a provider of inventory intelligence solutions for healthcare, announced today a significant $300M strategic partnership with a newly formed financing vehicle sponsored by Warburg Pincus, a growth private equity firm.  - The investment will fuel Mashura's expansion plans, drive innovation in its core offerings, and strengthen its integration partnerships. Inventory Intelligence Solutions Mashura specializes in providing smart cabinet
Read More

Providence Ventures Spins Out, Forms Allumia Ventures

by Fred Pennic 01/07/2025 Leave a Comment

Providence Ventures Spins Out, Forms Allumia Ventures

What You Should Know:  - Allumia Ventures, formerly known as Providence Ventures, announced its spin-off from Providence to become an independent venture capital firm.  - The spin out follows the first close of its third fund, marking a significant milestone in the firm's evolution. The firm will continue to work closely with Providence as an Anchor Limited Partner while inviting a select group of other healthcare organizations to join its third fund. Allumia Ventures
Read More

ONRAD Acquires Direct Radiology from Philips, Creating Largest Independent Teleradiology Provider in the US

by Fred Pennic 01/07/2025 Leave a Comment

ONRAD Acquires Direct Radiology from Philips, Creating Largest Independent Teleradiology Provider in the US

What You Should Know:  - ONRAD Inc., a provider of teleradiology and comprehensive radiology solutions, announced the acquisition of Direct Radiology from Royal Philips. Financial terms of the acquisition were not disclosed.  - Direct Radiology, founded in 2012, is a Joint Commission-accredited practice with a network of approximately 80 radiologists serving over 430 healthcare facilities across the US. By integrating Direct Radiology's extensive network and expertise, ONRAD
Read More

5 Vocal Biomarker Trends to Watch in 2025

by Henry O’Connell, CEO and Co-Founder, Canary Speech 01/07/2025 Leave a Comment

5 Vocal Biomarker Trends to Watch in 2025

In recent years, the use of AI-enhanced ambient listening tools has transformed the way clinicians utilize vocal biomarkers for cognitive and behavioral health assessments. As these technologies expand, clinicians are exploring use-cases for a wider range of languages, populations, and more conditions as well. Looking ahead to 2025, expect vocal biomarkers to play a more essential role in disease detection, offering valuable insights while saving time for both
Read More

Twentyeight Health Secures $10M to Expand Access to Affordable Women’s Healthcare

by Jasmine Pennic 01/07/2025 Leave a Comment

Twentyeight Health Secures $10M to Expand Access to Affordable Women's Healthcare

What You Should Know:  - Twentyeight Health, a digital-first women's healthcare platform raises $10M in a Series A funding round led by Seae Ventures, with participation from Impact America Fund, The Social Entrepreneurs' Fund, RH Capital, Impact Engine, Gratitude Railroad, and Townhall Ventures.  - The latest round brings the company's total funding to $25M and will fuel its mission to provide convenient, affordable, and stigma-free reproductive and sexual care to women across
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 50
  • Go to page 51
  • Go to page 52
  • Go to page 53
  • Go to page 54
  • Interim pages omitted …
  • Go to page 728
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |